Evidence map›Paper›PMID 37656946›Full record

ArticleJCO global oncology2023

Current Challenges of Asian National Children's Cancer Study Groups on Behalf of Asian Pediatric Hematology and Oncology Group.

Chi-Kong Li, Purna Kurkure, Ramandeep Singh Arora, Bow Wen Chen, Kirill Kirgizov, Yasuhiro Okamoto, Panya Seksarn, Yongmin Tang, Keon Hee Yoo, Bharat Agarwal and 6 more

Abstract read
In one paragraph

Article in JCO global oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Pediatric Oncology Hospice: A Comprehensive Review.The American journal of hospice & palliative care · 2024
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Chi-Kong LiDepartment of Paediatrics, The Chinese University of Hong Kong, Hong Kong Children's Hospital, Hong Kong SAR, China.ORCID 0000-0002-2810-5758
Purna KurkureDivision of Pediatric Hemato Oncology & BMT, SRCC Children's Hospital Haji Ali, Mumbai, India.ORCID 0000-0003-4443-2203
Ramandeep Singh AroraPediatric Oncology Disease Management Group, Max Super Specialty Hospital, New Delhi, India.ORCID 0000-0002-2613-4539
Bow Wen ChenKoo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan.
Kirill KirgizovN.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia.
Yasuhiro OkamotoDepartment of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Sakuragaoka Kagoshima, Japan.ORCID 0000-0003-4412-6441
Panya SeksarnDepartment of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.ORCID 0000-0002-3125-9918
Yongmin TangDepartment of Hematology-Oncology, the Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Keon Hee YooDepartment of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.ORCID 0000-0002-5980-7912
Bharat AgarwalDepartment of Pediatric Hematology & Oncology, B J Wadia Hospital for Children, Parel, Mumbai, India.
Godfrey C F ChanDepartment of Paediatrics & Adolescent Medicine, The University of Hong Kong, Hong Kong Children's Hospital, Hong Kong SAR, China.ORCID 0000-0001-5032-8985
Rashmi DalviDepartment of Pediatrics, Bombay Hospital Institute of Medical Sciences, Bombay, India.ORCID 0000-0002-8883-7088
Hiroki HoriGraduate School of Medicine, Mie University in Tsu, Tsu, Japan.
Muhammad Saghir KhanDepartment of Pediatrics, King Faisal Specialist Hospital and Research Center, Al Madinah, Kingdom of Saudi Arabia.ORCID 0000-0003-4213-275X
Alice YuInstitute of Stem Cell & Translational Research, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.ORCID 0000-0003-2444-0505
Akira NakagawaraSaga International Carbon Particle Beam Radiation Cancer Therapy Center, Saga HIMAT Foundation, Harakoga-Machi, Saga, Japan.ORCID 0000-0003-3732-7763

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Asia, a few countries have a long and established history of collaborative clinical trials successfully formed national children's cancer study groups, but many still do not have such groups. The process of forming national children's cancer groups is fraught with many hurdles, which varies among the countries. One of the basic requirements for running clinical trials is an affordable health care system in which most of the children with cancer can receive the proposed treatment. The health insurance coverage for children with cancer varies from <20% to as high as 100% among Asian countries, and the operation of clinical trials must also be adjusted accordingly. Shortage of research personnel is common, including medical, nursing, research coordinators, and data managers. The establishment of the Asian Pediatric Hematology and Oncology Group aims to provide a good platform for promotion of international clinical trials in the Asian countries.

Indexed as

HematologyNeoplasmsAsiaChildHumans

Identifiers

PMID37656946
PMCPMC10581612

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.